Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Circ Cardiovasc Qual Outcomes ; 13(7): e006612, 2020 07.
Article in English | MEDLINE | ID: mdl-32683984

ABSTRACT

In spring 2018, the American Heart Association convened the Value in Healthcare Summit to begin an important conversation about the challenges patients with cardiovascular disease face in accessing and deriving quality and value from the healthcare system. Following the summit and recognizing the collective momentum it created, the American Heart Association, in collaboration with the Robert J. Margolis Center for Health Policy at Duke University, launched the Value in Healthcare Initiative-Transforming Cardiovascular Care. Four areas of focus were identified, and learning collaboratives were established and proceeded to conduct concrete, actionable problem solving in 4 high-impact areas in cardiovascular care: Value-Based Models, Partnering with Regulators, Predict and Prevent, and Prior Authorization. The deliverables from these groups are being disseminated in 4 stand-alone articles, and their publication will initiate further work to test and evaluate each of these promising areas of reform. This article provides an overview of the initiative's findings and highlights key cross-cutting themes for consideration as the initiative moves forward.


Subject(s)
Cardiovascular Diseases/economics , Cardiovascular Diseases/therapy , Health Care Costs , Health Services Research/economics , Cardiovascular Diseases/diagnosis , Cooperative Behavior , Cost Savings , Cost-Benefit Analysis , Device Approval , Diffusion of Innovation , Drug Approval/economics , Humans , Interdisciplinary Communication , Leadership , Preventive Health Services/economics , Prior Authorization/economics , Value-Based Health Insurance/economics , Value-Based Purchasing/economics
3.
Circulation ; 141(10): e615-e644, 2020 03 10.
Article in English | MEDLINE | ID: mdl-32078375

ABSTRACT

Understanding and addressing the unique health needs of people residing in rural America is critical to the American Heart Association's pursuit of a world with longer, healthier lives. Improving the health of rural populations is consistent with the American Heart Association's commitment to health equity and its focus on social determinants of health to reduce and ideally to eliminate health disparities. This presidential advisory serves as a call to action for the American Heart Association and other stakeholders to make rural populations a priority in programming, research, and policy. This advisory first summarizes existing data on rural populations, communities, and health outcomes; explores 3 major groups of factors underlying urban-rural disparities in health outcomes, including individual factors, social determinants of health, and health delivery system factors; and then proposes a set of solutions spanning health system innovation, policy, and research aimed at improving rural health.


Subject(s)
Cardiovascular Diseases/epidemiology , Rural Health Services , Rural Health , Rural Population , Stroke/epidemiology , American Heart Association , Health Services Accessibility , Humans , Quality Improvement , United States/epidemiology
4.
Circulation ; 136(24): e441-e447, 2017 Dec 12.
Article in English | MEDLINE | ID: mdl-29122813

ABSTRACT

Net US spending on pharmaceuticals reached $309.5 billion in 2015, an 8.5% increase from the year before, and is expected to reach between $370 and $400 billion by 2020. These current and projected levels have raised serious concerns by policy makers, providers, payers, and patient groups that they are unsustainable and threaten the affordability of and accessibility to much-needed therapies for patients. Two trends related to drugs/biologics and generic drugs/biosimilars underlie this overall increase in spending. First, the market entry prices of innovator pharmaceutical products, or brand drugs and biologics, are at levels that some assessments consider unaffordable to the healthcare system. Second, prices for some established generic drugs such as digoxin and captopril have seen sharp and rapid increases. As an evidence-based patient advocacy organization dedicated to improving the cardiovascular health of all Americans, the American Heart Association has a unique role in advocating for treatments, including medicines that are available, affordable, and accessible to patients. This advisory serves to lay out a set of principles that will guide association engagement in pursuit of this goal.


Subject(s)
Biosimilar Pharmaceuticals/therapeutic use , Cardiovascular Diseases/drug therapy , Drugs, Generic/therapeutic use , American Heart Association , Biosimilar Pharmaceuticals/economics , Cardiovascular Diseases/economics , Cardiovascular Diseases/epidemiology , Drug Costs , Drugs, Generic/economics , Evidence-Based Practice , Health Services Accessibility , Humans , Practice Guidelines as Topic , United States/epidemiology
5.
Circulation ; 136(7): e162-e171, 2017 Aug 15.
Article in English | MEDLINE | ID: mdl-28696250

ABSTRACT

The healthcare system is undergoing a transition from paying for volume to paying for value. Clinicians, as well as public and private payers, are beginning to implement alternative delivery and payment models, such as the patient-centered medical home, accountable care organizations, and bundled payment arrangements. Implementation of these new models will necessitate delivery system transformation and will actively involve all fields of medical care, in particular medicine and surgery. This call to action, on behalf of the American Heart Association's Expert Panel on Payment and Delivery System Reform, serves to offer support and direction for further involvement by the American Heart Association. In doing so, it (1) provides baseline review and definition of the present models and some of the early results of these delivery models, including outcomes; (2) initiates a conversation within the American Heart Association on the impact of payment and delivery system reform, as well as how the American Heart Association should engage in the interest of patients; (3) issues a call to action to our organization and to cardiovascular and stroke health professionals across the country to become educated about these models so to as to understand their impact on patient care; and (4) asks the government and other funding agencies, including the American Heart Association, to begin supporting and prioritizing meaningful research endeavors to further evaluate these models.


Subject(s)
Insurance, Health, Reimbursement , Quality of Health Care/economics , Accountable Care Organizations , American Heart Association , Health Expenditures , Health Policy/economics , Humans , United States
6.
NASN Sch Nurse ; 31(5): 263-70, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27486226

ABSTRACT

A sudden cardiac arrest in school or at a school event is potentially devastating to families and communities. An appropriate response to such an event-as promoted by developing, implementing, and practicing a cardiac emergency response plan (CERP)-can increase survival rates. Understanding that a trained lay-responder team within the school can make a difference in the crucial minutes between the time when the victim collapses and when emergency medical services arrive empowers school staff and can save lives. In 2015, the American Heart Association convened a group of stakeholders to develop tools to assist schools in developing CERPs. This article reviews the critical components of a CERP and a CERP team, the factors that should be taken into account when implementing the CERP, and recommendations for policy makers to support CERPs in schools.


Subject(s)
Cardiopulmonary Resuscitation/standards , Defibrillators , Emergency Medical Services/standards , Emergency Treatment/standards , Heart Arrest/therapy , Practice Guidelines as Topic , School Nursing/standards , Adolescent , Adult , Child , Emergency Medical Services/legislation & jurisprudence , Female , Humans , Male , Middle Aged , School Nursing/legislation & jurisprudence , United States
7.
Circulation ; 134(11): e198-225, 2016 Sep 13.
Article in English | MEDLINE | ID: mdl-27503067

ABSTRACT

The mission of the American Heart Association/American Stroke Association includes increasing access to high-quality, evidence-based care that improves patient outcomes such as health-related quality of life and is consistent with the patients' values, preferences, and goals. Awareness of and access to palliative care interventions align with the American Heart Association/American Stroke Association mission. The purposes of this policy statement are to provide background on the importance of palliative care as it pertains to patients with advanced cardiovascular disease and stroke and their families and to make recommendations for policy decisions. Palliative care, defined as patient- and family-centered care that optimizes health-related quality of life by anticipating, preventing, and treating suffering, should be integrated into the care of all patients with advanced cardiovascular disease and stroke early in the disease trajectory. Palliative care focuses on communication, shared decision making about treatment options, advance care planning, and attention to physical, emotional, spiritual, and psychological distress with inclusion of the patient's family and care system. Our policy recommendations address the following: reimbursement for comprehensive delivery of palliative care services for patients with advanced cardiovascular disease and stroke; strong payer-provider relationships that involve data sharing to identify patients in need of palliative care, identification of better care and payment models, and establishment of quality standards and outcome measurements; healthcare system policies for the provision of comprehensive palliative care services during hospitalization, including goals of care, treatment decisions, needs of family caregivers, and transition to other care settings; and health professional education in palliative care as part of licensure requirements.


Subject(s)
Palliative Care , Quality of Life , Stroke/therapy , American Heart Association , Caregivers/legislation & jurisprudence , Caregivers/standards , Humans , Palliative Care/legislation & jurisprudence , Palliative Care/standards , Patient Comfort/legislation & jurisprudence , Patient Comfort/standards , United States
8.
Am Heart J ; 175: 130-41, 2016 05.
Article in English | MEDLINE | ID: mdl-27179732

ABSTRACT

Shortages of cardiovascular drugs have become increasingly common, representing an ongoing public health crisis. Given few therapeutic alternatives to many of the drugs in short supply, these shortages also pose a major challenge for cardiovascular care professionals. Although changes in the regulatory environment have led to some improvements in recent years, problems involving manufacturing processes remain the most common underlying cause. Because of the complex nature of drug shortages, sustainable solutions to prevent and mitigate them will require collaboration between regulatory agencies, drug manufacturers, and other key stakeholder groups. In this report, we describe the scope of the cardiovascular drug shortage crisis in the United States, including its underlying causes and the efforts currently being made to address it. Furthermore, we provide specific recommendations for how cardiovascular care professionals can be involved in efforts to limit the impact of drug shortages on patient care as well as policy changes aimed at preventing and mitigating them.


Subject(s)
Cardiovascular Agents/supply & distribution , Cardiovascular Diseases/drug therapy , Health Services Accessibility/standards , Health Services Needs and Demand , Humans , Quality Improvement , United States
10.
J Health Care Poor Underserved ; 20(1): 98-106, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19202250

ABSTRACT

OBJECTIVE: To examine how the safety net in Michigan is responding to the health care needs of their uninsured population with diabetes and/or mental illness. METHODS: We used a multiple-site case study design. Data were collected through interviews of key informants in five Michigan communities. Analytic patterns and themes were identified, and compared across communities and by organizational type. RESULTS: Informants reported they are managing to meet the needs of uninsured diabetics but are having great difficulty caring for the uninsured with mental illness. Specialty care for diabetes is obtainable, but is resource-intensive. Mental health services available for uninsured patients are severely limited. The presence of a county health plan (CHP) appears insufficient to improve access, especially to mental health services. CONCLUSIONS: The safety net for Michigan's uninsured population with diabetes and mental illness is weak. Processes including referrals and care coordination are of poor quality in some communities. The value of integrating mental health services into primary care should be examined.


Subject(s)
Community Health Services/organization & administration , Diabetes Mellitus/therapy , Medically Uninsured , Mental Health Services/organization & administration , Community Mental Health Services/organization & administration , Health Services Needs and Demand , Health Services Research , Humans , Michigan , Primary Health Care/organization & administration
SELECTION OF CITATIONS
SEARCH DETAIL
...